Pfizer Inc (PFE) stock saw a decline, ending the day at $26.52 which represents a decrease of $-0.39 or -1.45% from the prior close of $26.91. The stock opened at $26.96 and touched a low of $26.42 ...

Pfizer (NYSE:PFE) reported positive topline results from a Phase 3 study of its drug Braftovi, also known as encorafenib, in the treatment of a certain type of colorectal cancer. The study, called ...

Bullish option flow detected in Pfizer (PFE) with 33,534 calls trading, 1.3x expected, and implied vol increasing over 1 point to 27.48%. 2/7 ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the ...

US stock futures fell sharply Monday, with the imposition of tariffs on major trading partners by the Trump administration hitting sentiment. Tesla (NASDAQ:TSLA) stock fell 3.2%, with the EV maker ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Last week was extremely busy on the earnings front, so this week is a little more sedate. That being said, we still have some ...

MADRID - Inspired by Donald Trump's MAGA slogan, parties aligned with the Patriots for Europe group will gather in Madrid on ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

With its new government, Belgium joins a growing list of European countries led by nationalist forces such as Meloni's Italy ...

Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established to boost the pipeline of Black, Latino and Native American people in ...